| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 23736-58-5 | 芐星鄰氯青霉素; 鄰氯芐星 | Cloxacillin benzathine; (2S-(2alpha,5alpha,6beta))-6-(((3-(2-Chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid N,N'-bis(phenylmethyl)-1,2-ethanediamine (2:1) |  | 2(C19H18ClN3O5S).C16H20N2 | 詳情 | 供應商 |
| 35665-38-4 | N-芴甲氧羰基-甘氨酰-甘氨酸 | Fmoc-Gly-Gly-OH; N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycyl-glycine; Fmoc-glycyl-glycine |  | C19H18N2O5 | 詳情 | 供應商 |
| 59564-78-2 | 1,3-二芐基咪唑-2-酮-4,5-二羧酸; 環(huán)酸 | 1,3-Bisbenzyl-2-oxoimidazolidine-4,5-dicarboxylic acid; 1,3-DIBENZYL IMIDAZOLIDINONE-4,5-DICARBOXYLIC ACID; 1,3-BISBENZYL-2-OXOIMIDAZOLIDINE-4,5-DICARBOXYLIC ACID; 1,3-Dibenzyl-2-Imidaxzolidone-Cis-4,5-Dicarboxylic Acid; Vitamin H intermediates Cyclic acid; 1,3-BISBENZYL-2-OXOIMIDAZOLIDINE-4,5-DI&; CYCLIC ACID; 1,3-Dibenzyl-2-imidax zolidone-cis-4,5-dicarboxylic |  | C19H18N2O5 | 詳情 | 供應商 |
| 71989-16-7 | Fmoc-L-天冬酰胺; 芴甲氧羰基-L-天冬酰胺 | Nalpha-FMOC-L-Asparagine; Fmoc-Asn-OH; FMOC-L-Asparagine; Nalpha-(9-Fluorenylmethoxycarbonyl)-L-asparagine |  | C19H18N2O5 | 詳情 | 供應商 |
| 108321-39-7 | Fmoc-D-天冬酰胺; N-芴甲氧羰基-D-天冬酰胺 | Fmoc-D-Asparagine; Fmoc-D-Asn-OH; N-9-Fluorenylmethoxycarbonyl-D-asparagine |  | C19H18N2O5 | 詳情 | 供應商 |
| 151606-29-0 | Acetic acid,2-[[2-methyl-8-[[(4-methylphenyl)sulfonyl]amino]-6-quinolinyl]oxy]-; Aceticacid, [[2-methyl-8-[[(4-methylphenyl)sulfonyl]amino]-6-quinolinyl]oxy]- (9CI); Zinquin; Zinquin A |  | C19H18N2O5S | 詳情 | 供應商 | |
| 200335-41-7 | Fmoc-D-Asp-NH2 | Butanoic acid,4-amino-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-oxo-, (3R)-; Fmoc-D-Asp-NH2 |  | C19H18N2O5 | 詳情 | 供應商 |
| 107754-15-4 | Benzoic acid,3-methoxy-4-[(1-methyl-5-nitro-1H-indol-3-yl)methyl]-, methyl ester; Methyl-Benzoate,Zafirlukast,; Methyl-3-Methoxy-4-[(1-Methyl-5-Nitro 1H-Indol-3-yl) Methyl]-Benzoate |  | C19H18N2O5 | 詳情 | 供應商 | |
| 200335-40-6 | Butanoic acid,4-amino-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-oxo-, (3S)-; N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-L-ASPARTIC ACID ALPHA-AMIDE; N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-L-ISOASPARAGINE; FMOC-L-ISOASPARAGINE; FMOC-L-ASPARTIC ACID ALPHA-AMIDE; FMOC-ISOASN-OH; FMOC-ASP-NH2; FMOC-ASPARTIC ACID-NH2 |  | C19H18N2O5 | 詳情 | 供應商 | |
| 65277-71-6 | L-Aspartic acid,N-(phenylacetyl)-, 4-(phenylmethyl) ester, monopotassium salt (9CI); Potassiumphenylacetyl-L-aspartic acid-b-benzyl ester |  | C19H18KNO5 | 詳情 | 供應商 | |
| 1948-22-7 | L-Glutamic acid,N-[3,5-dibromo-4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-; Glutamicacid, N-[3,5-dibromo-4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-(6CI,7CI); Glutamic acid,N-[3,5-dibromo-4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, L- (8CI); 3',5'-Dibromoaminopterin |  | C19H18Br2N8O5 | 詳情 | 供應商 | |
| 114149-34-7 | 1H-Indene-5-butanoicacid, 2-[[(4-chlorophenyl)sulfonyl]amino]-2,3-dihydro-g-oxo- |  | C19H18ClNO5S | 詳情 | 供應商 | |
| 85302-26-7 | 2H-1-Benzopyran-8-sulfonamide,4,5,7-trimethyl-2-oxo-N-[(phenylamino)carbonyl]-; 4,5,7-Trimethyl-2-oxo-N-((phenylamino)carbonyl)-2H-1-benzopyran-8-sulf onamide |  | C19H18N2O5S | 詳情 | 供應商 | |
| 51591-75-4 | 順1,3-二芐基咪唑-2-酮-4,5-二羧酸 | 4,5-Imidazolidinedicarboxylicacid, 2-oxo-1,3-bis(phenylmethyl)-, (4R,5S)-rel-; 4,5-Imidazolidinedicarboxylicacid, 1,3-dibenzyl-2-oxo-, cis- (5CI); 4,5-Imidazolidinedicarboxylic acid,2-oxo-1,3-bis(phenylmethyl)-, cis-; (4R,5S)-rel-2-Oxo-1,3-bis(phenylmethyl)-4,5-imidazolidinedicarboxylic acid; cis-1,3-Dibenzyl-2-imidazolidone-4,5-dicarboxylic acid |  | C19H18N2O5 | 詳情 | 供應商 |
| 26339-40-2 | 4,5-Imidazolidinedicarboxylicacid, 1,3-dibenzyl-2-oxo-, trans- (8CI); 1,3-dibenzyl-2-oxoimidazolidine-4,5-dicarboxylic acid |  | C19H18N2O5 | 詳情 | 供應商 | |
| 61-72-3 | 鄰氟苯唑青霉素 | CLOXACILLIN; [3-(o-chlorophenyl)-5-methyl-4-isoxazolyl]penicillin; 3-dimethyl-7-oxo-thyl-4-isoxazolecarboxamido)-; 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicacid,6-(3-(o-chlorophenyl)-5-me; 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicacid,6-(3-(o-chlorophenyl)-s-me; 6-(((3-(2-chlorophenyl)-5-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicaci; 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-o; 6-[3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxamido]penicillanicacid; brl1621 |  | C19H18ClN3O5S | 詳情 | 供應商 |
| 366789-02-8 | 5-氯-N-(((5S)-2-氧代-3-(4-(3-氧代嗎啉-4-基)苯基)-1,3-惡唑啉-5-基)甲基)噻吩-2-甲酰胺 | Rivaroxaban; 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide; BAY 59-7939; Rivaroxaban; 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide; 2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]; Xarelto |  | C19H18ClN3O5S | 詳情 | 供應商 |
| 7060-81-3 | cloxacillin sodium; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo- |  | C19H18ClN3O5S | 詳情 | 供應商 | |
| 865479-71-6 | 5-R-Rivaroxaban |  | C19H18ClN3O5S | 詳情 | 供應商 | |
| 198471-83-9 | 帕瑞昔布鈉雜質T | Parecoxib Impurity T | 無 | C19H18N2O5S | 詳情 | 供應商 |